Clinical Treatment and Management of Pulmonary Arterial Hypertension
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: 25 July 2024 | Viewed by 98
Special Issue Editors
Interests: right ventricular dysfunction; pulmonary hypertension; pulmonary arterial hypertension
Interests: pediatric cardiology; pulmonary hypertension; pulmonary arterial hypertension
Special Issue Information
Dear Colleagues,
Pulmonary arterial hypertension (PAH) is a progressive and life-threatening condition characterized by high pressure in the lung arteries. Treatment of PAH aims to relieve symptoms, slow down disease progression, and improve quality of life; it often involves a combination of medication, lifestyle modifications, and in some cases, surgical interventions. Current commonly used medications include endothelin receptor antagonists, phosphodiesterase-5 inhibitors, and prostacyclin analogs, with several new therapies in the horizon. Regular monitoring and follow-up with healthcare professionals are essential for managing PAH. Without proper treatment, PAH can lead to right-sided heart failure, severe complications, and reduced life expectancy. However, with early diagnosis and appropriate management, many individuals with PAH can lead fulfilling lives.
I strongly encourage you to submit your original research or review papers about adult or pediatric PAH to our Special Issue and be a part of our vibrant scientific community.
Dr. Sasha Z. Prisco
Dr. Megan Griffiths
Dr. Michael Risbano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary arterial hypertension
- pulmonary hypertension
- pulmonary vascular remodeling
- right ventricle
- right ventricular–pulmonary artery uncoupling
- six-minute walk distance
